...
首页> 外文期刊>Veterinary Record Case Reports >The use of telmisartan in combination therapy in the management of nephrotic syndrome due to non-immune-mediated glomerulonephropathy in a young cat
【24h】

The use of telmisartan in combination therapy in the management of nephrotic syndrome due to non-immune-mediated glomerulonephropathy in a young cat

机译:替米沙坦治疗相结合的使用肾病综合症导致的管理non-immune-mediated glomerulonephropathy在年轻的猫

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

An 8-month-old male castrated domestic shorthair was referred with anorexia, polydipsia, lethargy and diarrhoea, which progressed to marked subcutaneous oedema. The cat had hypoalbuminaemia, hypercholesterolaemia, proteinuria and oedema; clinicopathological findings consistent with severe protein-losing nephropathy and nephrotic syndrome. Histopathology of ultrasound-guided percutaneous renal biopsies identified marked podocyte injury with associated focal segmental glomerulosclerosis, a condition rarely reported in cats. The cat fully recovered following medical management with prednisolone and telmisartan, with the resolution of proteinuria.
机译:一个八个月大的雄性阉割国内短毛猫被称为有厌食症、烦渴、嗜睡吗和腹泻,进步明显皮下水肿。蛋白尿和水肿;结果符合严重蛋白质损失率肾病、肾病综合症。组织病理学超声引导经皮足突细胞损伤肾活检发现明显与相关的焦段肾小球硬化症,很少报道在猫。医疗管理与强的松替米沙坦,蛋白尿的决议。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号